A recent study reveals that a common blood test used to detect ovarian cancer may not accurately identify the disease in Black and Native American patients, leading to delayed treatment. The research highlights significant healthcare disparities related to race, with Native American women experiencing the highest rates of ovarian cancer and Black women having poorer survival rates than white counterparts. Experts emphasize the need for medical tests to consider genetic diversity and race to improve outcomes.
"Finding ovarian cancer early can lead to better chances of survival. This is particularly critical for Black and Native American women, who face higher rates of late-stage diagnosis."
"This is a perfect example of work that absolutely needed to be stratified based on race and ethnicity. Understanding test performance across different populations is crucial for effective care."
Collection
[
|
...
]